Link
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
Organization: JAMA NetworkPublished: 2021
"This article outlines the threat newer SARS-CoV-2 variants pose to the effectiveness of current SARS-CoV-2 vaccines. The mutations some SARS-CoV-2 variants have developed to better evade the vaccine-induced immunity that SARS-CoV-2 vaccines provide are discussed. Several recommended actions that international, state, and individual actors can take to help mitigate the threat of newer SARS-CoV-2 variants are also provided." - SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
Resource Group:
Background Knowledge
Product Type: Article
Outbreaks and Pandemics
COVID-19
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Product Type: Article
Category:
Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Vaccine Safety and Development,Research and Development,Vaccine Effectiveness and Efficacy Monitoring and SurveillanceOutbreaks and Pandemics
COVID-19
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Audience:
Health Care Professional
Region: International
Region: International
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.